Clinical Trial Update: A Single-arm Phase II Trial of SAcituzumab Govitecan and Trastuzumab for HER2+ Metastatic Breast Cancer After Trastuzumab dEruxtEcaN (SATEEN) [Phase 2]

View source ↗

Summary

Phase II, single-arm trial (SATEEN) evaluating sacituzumab govitecan in combination with trastuzumab for HER2-positive metastatic breast cancer after prior tras…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Sacituzumab Govitecan (sacituzumab govitecan)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: Adrienne G. Waks | Conditions: Her 2 Positive Breast Cancer, Breast Cancer Female | Phase 2 | Status: ACTIVE_NOT_RECRUITING